Pembrolizumab for Progressive Multifocal Leukoencephalopathy Due to Primary Immunodeficiency

Neurology: Neuroimmunology and NeuroInflammation - United States
doi 10.1212/nxi.0000000000000628
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Progressive Multifocal Leukoencephalopathy

Journal of Multiple Sclerosis
2013English

Progressive Multifocal Leukoencephalopathy

Neurology
Neurology
2002English

Progressive Multifocal Leukoencephalopathy: Current Insights

Degenerative Neurological and Neuromuscular Disease
2019English

Mirtazapine Use in Human Immunodeficiency Virus–Infected Patients With Progressive Multifocal Leukoencephalopathy

Archives of Neurology
2009English

Rituximab-Associated Inflammatory Progressive Multifocal Leukoencephalopathy

Case Reports in Infectious Diseases
2016English

Germline Genetic Risk Variants for Progressive Multifocal Leukoencephalopathy

Frontiers in Neurology
Neurology
2020English

Progressive Multifocal Leukoencephalopathy: Clinical and Molecular Aspects

Reviews in Medical Virology
VirologyInfectious Diseases
2011English

Cerebellar Form of Progressive Multifocal Leukoencephalopathy (PML)

Canadian Journal of Neurological Sciences
MedicineNeurology
1979English

Progressive Multifocal Leukoencephalopathy in the Absence of Immunosuppression

Journal of NeuroVirology
VirologyNeurologyCellularMolecular Neuroscience
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy